Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Long

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Peptides|November 1, 1993
Chronic intracerebroventricular infusion of the antiopioid peptide, Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 (NPFF), downregulates mu opioid binding sites in rat brainR B Rothman, L S Brady, H Xu, et al.
Journal of Minimally Invasive Gynecology|September 29, 2016
Robotic Resection of Intravesical Polypropylene Mesh Following Tension Free Tape ProcedureB M Lingenfelter, C Russman, J B Long, et al.
Brain Research|January 16, 1989
Chronic morphine increases mu-opiate receptor binding in rat brain: a quantitative autoradiographic studyL S Brady, M Herkenham, J B Long, et al.
NIDA Research Monograph|January 1, 1986
In vivo interactions among opiate receptor agonists and antagonistsJ W Holaday, F C Tortella, R Maneckjee, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1993
The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious ratsK Dosaka-Akita, F C Tortella, J W Holaday, et al.
Proceedings of the Western Pharmacology Society|January 1, 1984
Dynorphin: cardiovascular consequences of opioid receptor interactions in normal and endotoxemic ratsJ W Holaday, J R Kenner, C E Glatt, et al.
Neuropeptides|December 1, 1984
ICI 174864, a putative delta opioid antagonist, reverses endotoxemic hypotension: pretreatment with dynorphin 1-13, A kappa agonist, blocks this actionJ B Long, B A Ruvio, C E Glatt, et al.
Surgery, Gynecology & Obstetrics|January 1, 1985
Asymptomatic carotid diseaseJ B Long, T G Lynch, R G Karanfilian, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1988
Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor, sensory and autonomic functionJ B Long, J M Petras, W C Mobley, et al.
Central Nervous System Trauma : Journal of the American Paralysis Association|January 1, 1986
Endogenous opioids in spinal cord injury: a critical evaluationJ B Long, A Martinez-Arizala, J M Petras, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Peptides|November 1, 1993
Chronic intracerebroventricular infusion of the antiopioid peptide, Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 (NPFF), downregulates mu opioid binding sites in rat brainR B Rothman, L S Brady, H Xu, et al.
Journal of Minimally Invasive Gynecology|September 29, 2016
Robotic Resection of Intravesical Polypropylene Mesh Following Tension Free Tape ProcedureB M Lingenfelter, C Russman, J B Long, et al.
Brain Research|January 16, 1989
Chronic morphine increases mu-opiate receptor binding in rat brain: a quantitative autoradiographic studyL S Brady, M Herkenham, J B Long, et al.
NIDA Research Monograph|January 1, 1986
In vivo interactions among opiate receptor agonists and antagonistsJ W Holaday, F C Tortella, R Maneckjee, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1993
The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious ratsK Dosaka-Akita, F C Tortella, J W Holaday, et al.
Proceedings of the Western Pharmacology Society|January 1, 1984
Dynorphin: cardiovascular consequences of opioid receptor interactions in normal and endotoxemic ratsJ W Holaday, J R Kenner, C E Glatt, et al.
Neuropeptides|December 1, 1984
ICI 174864, a putative delta opioid antagonist, reverses endotoxemic hypotension: pretreatment with dynorphin 1-13, A kappa agonist, blocks this actionJ B Long, B A Ruvio, C E Glatt, et al.
Surgery, Gynecology & Obstetrics|January 1, 1985
Asymptomatic carotid diseaseJ B Long, T G Lynch, R G Karanfilian, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1988
Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor, sensory and autonomic functionJ B Long, J M Petras, W C Mobley, et al.
Central Nervous System Trauma : Journal of the American Paralysis Association|January 1, 1986
Endogenous opioids in spinal cord injury: a critical evaluationJ B Long, A Martinez-Arizala, J M Petras, et al.
Pageof 8